{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:41:08Z","timestamp":1788014468537,"version":"build-2784847793"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T00:00:00Z","timestamp":1262822400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s10549-009-0701-x","type":"journal-article","created":{"date-parts":[[2010,1,6]],"date-time":"2010-01-06T09:04:46Z","timestamp":1262768686000},"page":"553-566","source":"Crossref","is-referenced-by-count":25,"title":["Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer"],"prefix":"10.1007","volume":"122","author":[{"given":"Jenny Chia-Yun","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Hakama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahti","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Ming-Fang","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nea","family":"Malila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tytti","family":"Sarkeala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anssi","family":"Auvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry Yueh-Hsia","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Hsi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,7]]},"reference":[{"key":"701_CR1","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1002\/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H","volume":"75","author":"L Tabar","year":"1995","unstructured":"Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, Smith RA (1995) Efficacy of breast cancer screening by age. Cancer 75:2507\u20132517","journal-title":"Cancer"},{"key":"701_CR2","first-page":"9","volume":"2","author":"HH Chen","year":"1997","unstructured":"Chen HH, Duffy SW, Tabar L, Day NE (1997) Markov chain models for progression of breast cancer. Part I: tumour attributes and the preclinical screen-detectable phase. J Epidemiol Biostat 2:9\u201323","journal-title":"J Epidemiol Biostat"},{"key":"701_CR3","first-page":"25","volume":"2","author":"HH Chen","year":"1997","unstructured":"Chen HH, Duffy SW, Tabar L, Day NE (1997) Markov chain models for progression of breast cancer. Part II: prediction of outcomes for different screening regimes. J Epidemiol Biostat 2:25\u201335","journal-title":"J Epidemiol Biostat"},{"key":"701_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<21::AID-IJC5>3.0.CO;2-Z","volume":"78","author":"MS Lai","year":"1998","unstructured":"Lai MS, Yen MF, Kuo HS, Koong SL, Chen THH, Duffy SW (1998) Efficacy of breast-cancer screening for female relatives of breast-cancer-index cases: Taiwan multicentre cancer screening (TAMCAS). Int J Cancer 78:21\u201326","journal-title":"Int J Cancer"},{"key":"701_CR5","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1002\/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H","volume":"1995","author":"L Tabar","year":"1995","unstructured":"Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, Smith RA (1995) Efficacy of breast cancer screening by age. Cancer 1995:2507\u20132517","journal-title":"Cancer"},{"key":"701_CR6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1258\/096914105775220732","volume":"12","author":"H Weedon-Fekj\u00e6r","year":"2005","unstructured":"Weedon-Fekj\u00e6r H, Vatten LJ, Aalen OO, Lindqvist B, Tretli S (2005) Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results. J Med Screen 12:172\u2013178","journal-title":"J Med Screen"},{"key":"701_CR7","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.ejca.2004.06.017","volume":"40","author":"T Sarkeala","year":"2004","unstructured":"Sarkeala T, Anttila A, Forsman H, Luostarinen T, Saarenmaa I, Hakama M (2004) Process indicators from ten centres in the Finnish breast cancer screening programme from 1991 to 2000. Eur J Cancer 40:2116\u20132125. doi: 10.1016\/j.ejca.2004.06.017","journal-title":"Eur J Cancer"},{"key":"701_CR8","doi-asserted-by":"publisher","unstructured":"Wu JC, Anttila A, Yen AM, Hakama M, Saarenmaa I, Sarkeala T, Malila N, Auvinen A, Chiu SY, Chen THH (2009) Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region. Breast Cancer Res Treat (in press). doi: 10.1007\/s10549-009-0604-x","DOI":"10.1007\/s10549-009-0604-x"},{"key":"701_CR9","first-page":"307","volume":"45","author":"HH Chen","year":"1996","unstructured":"Chen HH, Duffy SW, Tabar L (1996) A markov chain method to estimate the tumour progression rate from preclinical to clinical phase, sensitivity and positive predictive value for mammography in breast cancer screening. The Stat 45:307\u2013317","journal-title":"The Stat"},{"key":"701_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.0006-341X.2000.00167.x","volume":"56","author":"THH Chen","year":"2000","unstructured":"Chen THH, Kuo HS, Yen MF, Lai MS, Tabar L, Duffy SW (2000) Estimation of sojourn time in chronic disease screening without data on interval cases. Biometrics 56:167\u2013172","journal-title":"Biometrics"},{"key":"701_CR11","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ijc.21310","volume":"118","author":"T Sarkeala","year":"2006","unstructured":"Sarkeala T, Hakama M, Saarenmaa I, Hakulinen T, Forsman H, Anttila A (2006) Episode sensitivity in association with process indicators in the Finnish breast cancer screening program. Int J Cancer 118:174\u2013179. doi: 10.1002\/ijc.21310","journal-title":"Int J Cancer"},{"key":"701_CR12","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jncimono\/1997.22.93","volume":"22","author":"SW Duffy","year":"1997","unstructured":"Duffy SW, Day NE, Tabar L, Chen HH, Smith TC (1997) Markov models of breast tumor progression: some age-specific results. J Natl Cancer Inst Monogr 22:93\u201397","journal-title":"J Natl Cancer Inst Monogr"},{"key":"701_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/jms.9.4.153","volume":"9","author":"A Anttila","year":"2002","unstructured":"Anttila A, Koskela J, Hakama M (2002) Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 9:153\u2013158","journal-title":"J Med Screen"},{"key":"701_CR14","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/sim.4780141404","volume":"14","author":"SW Duffy","year":"1995","unstructured":"Duffy SW, Chen HH, Tabar L, Day NE (1995) Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Statist Med 14:1531\u20131543","journal-title":"Statist Med"},{"key":"701_CR15","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2307\/2530699","volume":"42","author":"R Kay","year":"1986","unstructured":"Kay R (1986) A Markov model for analyzing cancer markers and disease states in survival studies. Biometrics 42:855\u2013865","journal-title":"Biometrics"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0701-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-009-0701-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-009-0701-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T16:32:26Z","timestamp":1559233946000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-009-0701-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,7]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["701"],"URL":"https:\/\/doi.org\/10.1007\/s10549-009-0701-x","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,7]]}}}